ALPS Medical Breakthroughs ETF (SBIO)

NYSEARCA: SBIO · IEX Real-Time Price · USD
33.74
+0.41 (1.24%)
At close: Jun 24, 2024, 2:10 PM
33.76
+0.02 (0.06%)
After-hours: Jun 24, 2024, 6:30 PM EDT
1.24%
Assets $101.97M
Expense Ratio 0.50%
PE Ratio n/a
Shares Out 3.13M
Dividend (ttm) $0.07
Dividend Yield 0.21%
Ex-Dividend Date Dec 21, 2023
Payout Ratio n/a
1-Year Return +7.26%
Volume 8,718
Open 33.70
Previous Close 33.32
Day's Range 33.70 - 34.06
52-Week Low 23.21
52-Week High 38.80
Beta 1.12
Holdings 108
Inception Date Dec 31, 2014

About SBIO

Fund Home Page

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol SBIO
ETF Provider SS&C
Index Tracked S-Network Medical Breakthroughs Index

Top 10 Holdings

27.55% of assets
Name Symbol Weight
Krystal Biotech, Inc. KRYS 3.77%
Alkermes plc ALKS 3.19%
Immunovant, Inc. IMVT 3.01%
Avidity Biosciences, Inc. RNA 2.81%
Merus N.V. MRUS 2.74%
Crinetics Pharmaceuticals, Inc. CRNX 2.71%
Denali Therapeutics Inc. DNLI 2.43%
Corcept Therapeutics Incorporated CORT 2.36%
Arcellx, Inc. ACLX 2.27%
Amicus Therapeutics, Inc. FOLD 2.25%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 21, 2023 $0.07106 Dec 27, 2023
Dec 19, 2019 $0.01585 Dec 27, 2019
Dec 20, 2018 $0.78406 Dec 27, 2018
Dec 21, 2017 $0.57949 Dec 28, 2017
Full Dividend History

News

Big Pharma Has the Firepower for Biotech Deal-Making

In the early innings of 2024, there was a flurry of consolidation in the biotech industry. It stoked hopes that this would finally be the year in which well-heeled blue-chip pharmaceutical companies w...

10 days ago - ETF Trends

Biopharma R&D Trends Could Bode Well for This ETF

Many investors hoping for a resurgence by biotech stocks have hitched their wagons to the Federal Reserve lowering interest rates. That's a practical bet because biotech is a rate-sensitive industry.

6 weeks ago - ETF Trends

Vector Space Biosciences (SBIO) Is Now Available for Trading on LBank Exchange

Road Town, Virgin Islands--(Newsfile Corp. - September 24, 2023) - LBank Exchange, a global digital asset trading platform, listed Vector Space Biosciences (SBIO) on September 15, 2023. For all users ...

9 months ago - Newsfile Corp

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

3 years ago - Kiplinger